Literature DB >> 19297740

Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum.

Makoto Kinoshita1, Yuji Nakatsuji, Masayuki Moriya, Tatsusada Okuno, Atsushi Kumanogoh, Misa Nakano, Toshiyuki Takahashi, Kazuo Fujihara, Keiko Tanaka, Saburo Sakoda.   

Abstract

Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system, and humoral immunity is suggested to play an important role in the pathogenesis. The identification of an anti-aquaporin-4 antibody (AQP4-Ab, neuromyelitis optica immunoglobulin G) in the sera of patients with NMO has led to the investigation on the pathogenicity of the autoantibody. Recent immunohistological analyses revealed the primary loss of AQP4 on astrocytes and complement deposition in active lesions of NMO. In this report, we show that astrocytes are susceptible to sera from AQP4-Ab-positive patients and undergo necrosis in a complement-dependent manner. Our results suggest the primary pathogenic role of AQP4-Ab in NMO.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297740     DOI: 10.1097/wnr.0b013e32832776f4

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  30 in total

1.  Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.

Authors:  Samira Saadoun; Patrick Waters; Claire MacDonald; B Anthony Bell; Angela Vincent; A S Verkman; Marios C Papadopoulos
Journal:  Ann Neurol       Date:  2012-02-28       Impact factor: 10.422

Review 2.  Current understanding of the epidemiologic and clinical characteristics of optic neuritis.

Authors:  Masanori Nakazawa; Hitoshi Ishikawa; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2021-05-22       Impact factor: 2.447

Review 3.  Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported.

Authors:  Axel Petzold; Gordon T Plant
Journal:  J Neurol       Date:  2013-05-23       Impact factor: 4.849

Review 4.  Experimental models of neuromyelitis optica: current status, challenges and future directions.

Authors:  Minshu Li; Yaping Yan
Journal:  Neurosci Bull       Date:  2015-06-24       Impact factor: 5.203

5.  Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.

Authors:  Mikihide Ogasawara; Akira Meguro; Tsutomu Sakai; Nobuhisa Mizuki; Toshiyuki Takahashi; Kazuo Fujihara; Hiroshi Tsuneoka; Keigo Shikishima
Journal:  Jpn J Ophthalmol       Date:  2016-03-25       Impact factor: 2.447

6.  Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications.

Authors:  Romain Marignier; Pascale Giraudon; Sandra Vukusic; Christian Confavreux; Jérôme Honnorat
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

7.  A novel monoclonal antibody against the C-terminal region of aquaporin-4.

Authors:  Julia Ramadhanti; Ping Huang; Osamu Kusano-Arai; Hiroko Iwanari; Toshiko Sakihama; Tasturo Misu; Kazuo Fujihara; Takao Hamakubo; Masato Yasui; Yoichiro Abe
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-08

8.  Emerging Targeted Therapies for Neuromyelitis Optica Spectrum Disorders.

Authors:  Cristina Valencia-Sanchez; Dean M Wingerchuk
Journal:  BioDrugs       Date:  2020-12-10       Impact factor: 5.807

Review 9.  Immunology of neuromyelitis optica: a T cell-B cell collaboration.

Authors:  Meike Mitsdoerffer; Vijay Kuchroo; Thomas Korn
Journal:  Ann N Y Acad Sci       Date:  2013-04       Impact factor: 5.691

10.  Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

Authors:  Samira Saadoun; Patrick Waters; B Anthony Bell; Angela Vincent; A S Verkman; Marios C Papadopoulos
Journal:  Brain       Date:  2010-01-04       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.